BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33536988
Number of visits today
1452
Number of downloads
16723508
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Wang Z, Liu Z, Yang Y, Kang L. Identification of biomarkers and pathways in hypertensive nephropathy based on the ceRNA regulatory network. BMC Nephrol 2020;21:476. [PMID: 33176720 DOI: 10.1186/s12882-020-02142-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Han X, Li B, Zhang S. MIR503HG: A potential diagnostic and therapeutic target in human diseases. Biomed Pharmacother 2023;160:114314. [PMID: 36736276 DOI: 10.1016/j.biopha.2023.114314] [Reference Citation Analysis]
2 Liu C, Ma K, Zhang Y, He X, Song L, Chi M, Han Z, Li G, Zhang Q, Liu C. Kidney diseases and long non-coding RNAs in the limelight. Front Physiol 2022;13:932693. [DOI: 10.3389/fphys.2022.932693] [Reference Citation Analysis]
3 Liu B, Lu T, Wang Y, Zhang G, Fu L, Yu M, Yang K, Cai H. Overexpression of LncRNA SNHG14 as a biomarker of clinicopathological and prognosis value in human cancers: A meta-analysis and bioinformatics analysis. Front Genet 2022;13:945919. [DOI: 10.3389/fgene.2022.945919] [Reference Citation Analysis]
4 Yang X, Zhou B, Zhou L, Cui L, Zeng J, Wang S, Shi W, Zhang Y, Luo X, Xu C, Xue Y, Chen H, Chen S, Wang G, Guo L, Jose PA, Wilcox CS, Wu S, Wu G, Zeng C. Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study. Front Cardiovasc Med 2022;9:794768. [DOI: 10.3389/fcvm.2022.794768] [Reference Citation Analysis]
5 Wei L, Yu Z, Liu L, Zhou Y, Bai X, Wang L, Bai M, Sun S. Integrated Analysis of the CircRNA-Based ceRNA Network in Renal Fibrosis Induced by Ischemia Reperfusion Injury. Front Genet 2022;12:793182. [DOI: 10.3389/fgene.2021.793182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Geng L, Wang Z, Tian Y. Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K. J Ovarian Res 2022;15:1. [PMID: 34980214 DOI: 10.1186/s13048-021-00933-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345